IIM
IMGN

Ironwood Investment Management’s Immunogen Inc IMGN Stock Holding History

Ironwood Investment Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-174,540
Closed -$5.18M – 181
2023
Q4 		$5.18M Sell
174,540
-106
-0.1% -$2.11K 2.72% 5
2023
Q3 		$2.77M Sell
174,646
-19,434
-10% -$323K 1.69% 11
2023
Q2 		$3.66M Buy
194,080
+327
+0.2% +$3.86K 2.11% 7
2023
Q1 		$744K Sell
193,753
-5,080
-3% -$21.7K 0.47% 68
2022
Q4 		$986K Buy
198,833
+21,233
+12% +$115K 0.65% 55
2022
Q3 		$849K Sell
177,600
-106
-0.1% -$559 0.59% 60
2022
Q2 		$800K Buy
177,706
+145
+0.1% +$630 0.53% 64
2022
Q1 		$845K Buy
+177,561
New +$983K 0.46% 76

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ironwood Investment Management's IMGN Position: Q1 2024 in Review

Ironwood Investment Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 174,540 shares — an estimated $5.18M sold.

Ironwood Investment Management first reported a position in IMGN in Q1 2022 and held it in 8 quarters. The position peaked at $5.18M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Ironwood Investment Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Ironwood Investment Management sold 174,540 Immunogen Inc shares in Q1 2024, an estimated $5.18M.
  • Ironwood Investment Management first reported a position in Immunogen Inc in Q1 2022 and held it in 8 quarters.
  • Ironwood Investment Management's Immunogen Inc position peaked at $5.18M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Ironwood Investment Management's 13F filing for Q1 2024, filed 15 May 2024.